AMPH vs GRMN · P/E 12, rev $732.0M vs P/E 28, rev $6.30B
Amphastar P (AMPH) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the AMPH and GRMN stock pages for the full models.
Not investment advice.